HOME › DRUGS › NIMODIPINE
ACTIVE SUBSTANCE / INN

NIMODIPINE

Brand name(s): NIMOTOP, NYMALIZE, NIMODIPINE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA018869
ANDA213409
ACTIVE SUBSTANCE
Nimodipine
REGULATORS
FDA
SPONSORS / MAH
AZURITY, BAYER PHARMS, ALKEM LABS LTD
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NIMODIPINEANDA076740BIONPHARMAPrescription
NIMODIPINEANDA201832SOFGEN PHARMSDiscontinued
NYMALIZENDA203340AZURITYDiscontinued
NYMALIZENDA203340AZURITYPrescription
NIMODIPINEANDA213409ALKEM LABS LTDNone (Tentative Approval)
NIMOTOPNDA018869BAYER PHARMSDiscontinued

FULL INTELLIGENCE ON NIMODIPINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →